Abstract: Abdominal wall reconstructions, and complex ventral hernia repairs in particular, pose significant challenges to surgeons and are associated with serious postoperative wound healing complications often related to poor tissue perfusion. Maintenance of adequate perfusion of central adipocutaneous tissue is critical for minimizing risk of wound-related complications following herniorrhaphy; however, accurate tissue perfusion assessment can be challenging in this setting. Technologies such as thermography and laser Doppler flowmetry are not widely used in clinical settings to assess tissue perfusion, and most surgeons currently rely upon subjective assessments of tissue viability to guide intraoperative decisions regarding reconstruction. New technological developments, including spectroscopic imaging and indocyanine green-based near-infrared laser fluorescence, permit quantitative, real-time, intraoperative visualization of tissue perfusion and have demonstrated sensitivity and accuracy in a variety of reconstructive settings. Evidence suggests these technologies can be used to optimize perfusion at the time of operation and prevent perfusion-related complications such as flap necrosis. Future studies and physician reports describing these perfusion assessment technologies in complex ventral hernia repair will supply important information regarding their utility in patients undergoing this procedure.
Introduction
Complex abdominal wall defects requiring surgical reconstruction may result from trauma, recurrence after prior repairs, tumor ablation/resection, or congenital defects. 1, 2 Incisional hernias, including ventral abdominal hernias, are among the most common type of abdominal wall defect, with reported incidences ranging from 4%-20% of abdominal wall reconstruction cases. 1, [3] [4] [5] [6] There are approximately 250,000 procedures of this type performed each year in the United States. 7 Repair of complex ventral abdominal hernias poses technical challenges to both plastic and reconstructive surgeons and general surgeons. 1, 8, 9 Providing adequate protection and functional support for abdominal organs can be difficult, and defects that are too large to be repaired via primary closure are commonly encountered. 9, 10 Surgeons must consider how to use existing muscle and fascia to reconstruct the abdominal wall, preserve the integrity of overlying soft tissues, and achieve wound closure with an optimal level of tension while maintaining adequate blood supply throughout the surgical procedure. 8, 9 The purpose of this review is to address the importance of accurately assessing intraoperative tissue perfusion in patients undergoing ventral abdominal herniorrhaphy and to provide an overview of emerging technologies for perfusion assessment in this setting.
Approaches to ventral abdominal herniorrhaphy
There has been a general evolution over the last two decades regarding the anatomic approach to repair of ventral hernias. In contrast to earlier perspectives, the anatomy is now viewed less as a single bulk unit and more as two separate units: adipocutaneous and myofascial. This view gained acceptance largely as a result of the components-separation technique first described in 1990 by Ramirez et al. 12 Preserving perfusion in ventral herniorrhaphy is partially dependent upon the level of tension applied during closure. It is desirable to achieve adequate myofascial exposure in order to allow wound closure with an optimal level of tension while preserving perfusion to adipocutaneous tissue. Adequate exposure of myofascial tissue facilitates tension-free closure, although damage caused during manipulation of the myofascia may compromise perfusion to adipocutaneous tissue. Too much tension, by contrast, may lead to dehiscence.
Despite awareness on the part of the surgeon regarding these issues, 13, 14 perfusion to the central abdominal adipocutaneous tissue is often compromised. In some cases, this issue may be compounded by limitations to blood flow caused by scarring from previous surgeries. The consequence of poor perfusion to this critical area often is delayed wound breakdown caused by necrosis. Ideally, the surgeon would prevent such necrosis by resecting all nonviable, hypoperfused tissue while leaving as much adequately perfused tissue as possible to minimize tension on the closure. Intraoperative decision making based on tissue perfusion is hindered by the lack of adequate, objective perfusion assessment tools. Without intraoperative quantification of perfusion, the surgeon typically closes the wound (unless there is obvious compromise warranting debridement), allows the tissue to demarcate postoperatively, and then performs necessary debridement and/or wound care. The need for postoperative debridement lengthens and complicates the recovery process and increases the risk for secondary surgery. Treatment of these complications adds unnecessary costs to the healthcare system. In this era of healthcare reform, additional costs and compromised outcomes are under scrutiny.
Various surgical approaches can be employed to address the challenges of achieving closure with optimal tension and preservation of tissue perfusion. For ventral herniorrhaphy, these include open and laparoscopic techniques, 13, [15] [16] [17] suture/ primary closure, 13, 14 components separation, 9, [11] [12] [13] [18] [19] [20] [21] [22] and use of biologic matrices and synthetic meshes. 7, 13, 14, 23 Burden of postsurgical complications associated with ventral herniorrhaphy Reported complication rates after complex ventral herniorrhaphy are as high as 54%.
11,24-27 Wound-related complications such as infection, seroma, skin necrosis, and dehiscence may result in additional surgical procedures, 9 ,26 longer inpatients stays, and additional outpatient care. A recent retrospective study of high-risk patients undergoing ventral hernia repair showed that the average cost of complications for patients with a potentially contaminated surgical site (n=529) ranged from ∼$4,350 for those who received a biologic matrix to ∼$17,300 for those whose hernias were repaired using synthetic mesh. 27 Complication costs for those who had primary repair alone averaged ∼$11,500. For those with an infected surgical site (n=182), average complication costs were ∼$9,000 at 18 months (all of these hernias were repaired using either a biologic matrix or primary repair alone). These types of wound-healing complications may arise from biomechanical problems, perfusion impairment, or contamination; more commonly, they are linked to an overlapping combination of these factors.
Wound infection rates reported in studies of patients treated with mesh products have ranged from 2%-26% 27-35 and from 4%-20% in studies of mixed patient populations receiving suture or mesh repair, 9, 26, [36] [37] [38] [39] [40] with reported per-patient infection-related costs of up to ∼$4,700.
27 Wound infection significantly increases the risk of hernia recurrence, 28,41 and in some cases it may necessitate reoperation for removal of implanted material. The reported incidence of explantation in the literature ranges from 1.5%-44.0%. 26, 30, 35, 42, 43 Seroma predisposes the patient to surgical-site infection and in some cases may lead to major complications, including the need for removal of mesh and revisional surgery. 9, 44 To prevent seroma formation, closed drains are often placed around the implanted material. 45 Despite preemptive measures, the reported incidence of seroma in retrospective and prospective studies ranges from 2%-78%, 9, 19, [32] [33] [34] [35] 39, 40, 44, 46, 47 with reported seroma-related complication costs averaging up to $260 per patient. 27 The rates of skin necrosis and wound dehiscence following ventral herniorrhaphy vary widely across published reports. A meta-analysis of 14 retrospective studies comprising 460 patients undergoing herniorrhaphy found a skin necrosis rate of 1.5%. 9 More recently published single-center case series of complex herniorrhaphy show considerably higher skin necrosis rates, ranging from 19.8%-31.6%. [48] [49] [50] Comorbid conditions such as atherosclerosis and chronic nicotine and alcohol use may compromise tissue perfusion and complicate wound healing. 10 Reported rates of wound dehiscence following ventral herniorrhaphy have ranged from ,1%-21%, 32,51 with causes of this variation most likely related to patient risk factors, procedural complexity, and surgical approach.
Maintaining tissue perfusion during and after reconstructive surgery
Optimal tissue perfusion/viability is paramount to reconstructive surgery; meticulous debridement of all infected or necrotic tissue is critical to successful outcomes. [52] [53] [54] Data from patients undergoing several types of reconstructive surgery (including ventral hernia repair) have shown that tissue ischemia is associated with complications that include infection, delayed wound healing, prosthesis extrusion/ explantation, recurrence, and flap necrosis. 9, 55, 56 Infections that occur in ischemic tissue lead to worse outcomes than infections that occur in well-perfused tissue. 56, 57 Several devices and technologies have been studied for assessment of tissue perfusion (Table 1) . 53, [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] Due to technical and practical limitations, however, most existing technologies are rarely used in everyday clinical practice. 53, [59] [60] [61] [62] [63] [68] [69] [70] Sodium fluorescein, an older technology that has been more commonly applied than other methods of perfusion assessment, is an injectable contrast dye that illuminates with ultraviolet light in perfused tissue areas. 63, 64 Although it is considered generally safe, rare incidences (,1%) of severe complications have included bronchospasm, respiratory arrest, and stroke. 64, 65 Fluorescein has a long half-life, which limits the ability to reinject during surgery, and the dye may leak from capillaries, which may yield fluorescence even in poorly perfused tissue. 63 The usefulness of fluorescein in patients with impaired renal function is limited; 71 moreover, its use requires darkness and reveals perfusion only in superficial dermis. 66, 67, 71 Due to the limitations of these older methods of assessment, the surgeon's clinical observation and judgment regarding tissue characteristics such as temperature, color, capillary refill, bleeding to pinprick, and tissue turgor are used as the standard of care for assessment of tissue-flap perfusion in reconstructive procedures. Clinical judgment, 
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Ferzoco however, is often inconsistent, as it is highly subjective and depends upon the experience and abilities of the individual surgeon. 53, 56, 72 There is an unmet need for reliable, accurate, and precise methods to objectively assess tissue perfusion intraoperatively during incisional herniorrhaphy, as many of the complications that occur following this procedure are due to inaccurate assessment of tissue perfusion at the time of repair.
Novel approaches to tissue perfusion assessment Near-infrared spectroscopy
Advances in pulse oximetry technology have led to the development of a noninvasive bedside near-infrared spectroscopy (NIRS) tissue-perfusion monitoring device that yields real-time, continuous measurement of tissue oxygenation. 73 The NIRS device probe emits light in wavelengths longer than visible light and in a narrower spectrum, penetrating to a depth of a few centimeters and measuring both oxyhemoglobin and deoxyhemoglobin. 73, 74 Few published reports are available regarding application of NIRS technology for intraoperative tissue perfusion. However, successful use of NIRS for intraoperative monitoring of tissue oxygen saturation has been demonstrated in patients undergoing abdominal aortic aneurysm surgery, 75 cardiac surgery, 76 and colorectal surgery. 77 According to one published report, NIRS yielded accurate and reliable intraoperative perfusion assessments when used repeatedly during abdominal wall reconstruction and other types of reconstructive surgeries. 74 Potential technical limitations that could affect accuracy of perfusion measurement include low penetration of the light signal into deeper tissues, the requirement to place the probe directly on the tissue surface, possible dampening of signal by high bilirubin levels, and the presence of conditions that obstruct blood flow (eg, atherosclerosis). 73 Pelletier et al 78 conducted a cost analysis of NIRS tissue oximetry flap monitoring in patients undergoing autologous breast reconstruction. In this study, patients were admitted to either the intensive care unit (n=25) or surgical floor (n=25) after surgery; all patients received continuous monitoring using NIRS tissue oximetry. Overall, four patients experienced flap-related vascular complications; all were detected by NIRS oximetry. Patients monitored on the surgical floor had a mean cost reduction of $1,937 compared with those monitored in the intensive care unit. The investigators concluded that NIRS tissue oximetry is an effective monitoring tool after breast reconstruction and can eliminate the need for specialized nursing care.
Orthogonal polarization spectral imaging
Another spectroscopic strategy for tissue perfusion assessment uses orthogonal, polarized light reflected off the tissue being studied, allowing for three-dimensional, realtime, continuous imaging of light-absorbing hemoglobin species within blood vessels and capillaries. Orthogonal polarization spectral (OPS) technology does not use dyes and the device is small, portable, and hand-held. 69, 72, 79 It has been investigated in imaging of both superficial tissues and numerous organs in humans and for intraoperative skin-flap assessment in animals. 69, 72, 79, 80 Intraoperative use of OPS imaging has been studied for measurement of microvascular perfusion in patients undergoing coronary artery bypass graft surgery who were assigned to minimal extracorporeal circulation or conventional extracorporeal circulation during the surgical procedure. 80 Potential limitations to its use are that the imaging probe must be placed directly on the tissue surface, 69 ,72 that imaging high-velocity blood flow (eg, arterial vessels) depends on secondary image analysis, 69 and that signal penetration depth is limited to 3 mm (must be inserted into the body to image deeply embedded tissues). 79 
indocyanine green imaging
Indocyanine green (ICG) is an iodinated contrast dye that can be visualized under infrared or near-infrared light; it has been used extensively in intraoperative investigations of flap perfusion. 81 Compared with fluorescein, ICG has a much higher molecular weight (775 versus 376) and, once injected, is much more highly bound to serum lipoproteins. 63 These features allow the dye to remain inside vessels 82 and in turn yield a more accurate assessment of blood flow dynamics. ICG is comparatively safer than sodium fluorescein for use in more rapid or repeated intraoperative assessments of tissue perfusion because it has a short plasma half-life (3-5 minutes), undergoes a high degree of hepatic clearance without modification, and has no known metabolites. 63, [82] [83] [84] The use of near-infrared wavelengths of light with ICG yields better translucence than sodium fluorescein. 84 Use of ICG nevertheless may be limited by the need for a nearinfrared reading device to visualize results. 84 Serious adverse events are rare, 84, 85 although ICG use is contraindicated in patients with known sensitivity to iodides or iodinated 
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Assessing tissue perfusion during ventral hernia repair contrast agents; anaphylactic reactions can occur (two deaths have been reported after ICG injection during cardiac catheterization). 86 
iCG-based intraoperative imaging technologies
Given the advantages of ICG as a means for visualizing tissue perfusion, a number of ICG-based technologies have been developed.
Photodynamic eye™
An near-infrared camera system that incorporates ICG fluorescence detection (Photodynamic Eye™; Hamamatsu Photonics, Hamamatsu City, Japan) when illuminated with a laser light-emitting diode has been investigated. The laser in this system emits light at wavelengths below the threshold for tissue damage. The camera is portable and maneuverable, and yields digitized, real-time images. 87 It has been developed for indications such as visualization of sentinel lymph nodes/tumors in cancer patients [88] [89] [90] and visualization of the sclerosant polidocanol during sclerotherapy in sclerotic veins. 87 Piwkowski et al 91 demonstrated the efficacy of this technology for assessment of intercostal muscle blood perfusion in a pilot study of patients undergoing pulmonary resection.
iC-view™
Similar to the Photodynamic Eye™, the IC-VIEW™ (Pulsion Medical Systems, AG, Munich, Germany) is a laser-fluorescence videography system that permits realtime visualization of ICG after intravenous injection. 67 The IC-VIEW™ employs an infrared filter to detect fluorescence of ICG following an intravenous bolus of 0.5 mg/kg. 67, 92 This device has been investigated for postoperative ICG assessment of tissue-flap perfusion in breast reconstruction, 93 intraoperative assessment in aesthetic abdominoplasty, 92 and free-flap transfer in several surgical models. 67, 94 IC-VIEW™ has been used for intraoperative monitoring of perforator-flap perfusion during abdominoplasty 92 as well as in acute and long-term postoperative follow-up in breast reconstruction. 93 Holm et al 67 showed the accuracy of IC-VIEW™ for tissue monitoring across several different tissue types in several different reconstructive surgeries, and Mothes et al 94 demonstrated that IC-VIEW™ tissue perfusion measurements predicted replantation failure more accurately than did clinical parameters such as surgeon ratings of tissue turgor, perfusion, bleeding, or temperature.
Fluorescence-Assisted Resection and exploration system
The Fluorescence-Assisted Resection and Exploration (FLARE™) system (owned by Beth Israel Deaconess Medical Center, Boston, MA, USA) is currently being developed for intraoperative assessment of tissue perfusion in breast reconstruction. 95, 96 FLARE™ elaborates on existing laserfluorescence imaging systems by incorporating both a NIRS laser light-emitting diode and a white light-emitting diode that generate a signal over a 15-cm diameter area. 96 This dual system allows capture of color video of the surgical-site anatomy as well as tissue perfusion at the surgical site. The system can display these images merged or separately. 96 Lee et al 95 reported results from a dosing study using FLARE™ for visualization of deep inferior epigastric-flap perfusion at several time points during breast surgery in six patients after 2 mg, 4 mg, or 6 mg doses of ICG. The authors reported that in two of the six patients studied, the dominant perforator identified by FLARE™ was not the perforator chosen by the surgeon during preoperative assessment using clinical judgment (ie, the surgeon chose an inferior vessel). 95 
D-Light P
The D-Light P (Karl Storz GmbH and Co, KG, Tuttlingen, Germany) is an ICG fluorescence-based NIRS laparoscope system that has been studied for intraoperative assessment of tissue perfusion in an experimental animal model by Diana et al. 97 The authors showed the D-Light P system to accurately detect boundaries between ischemic and vascularized areas of mesenteric ischemia in swine. To our knowledge, no studies describing the use of D-Light P for perfusion assessment in humans have been published.
The SPY Elite ® intraoperative perfusion assessment system (LifeCell Corporation, Branchburg, NJ, USA) is a widely used laser-ICG fluorescence imaging system currently indicated for intraoperative perfusion assessment in plastic, reconstructive, and gastrointestinal surgical procedures. 82, 86 Relative to the earlier SPY ® intraoperative perfusion assessment system, SPY Elite ® incorporates an updated laser with higher sensitivity and filtering power, allowing for fluorescence detection with lower ICG doses of 5 mg-10 mg per injection. 56 
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Ferzoco pedicle flaps, and free-tissue transfers, 56, 98, 99, [101] [102] [103] and in head and neck 104 and abdominal wall reconstruction surgeries. 100 The clinical utility of the SPY ® system in breast surgery has been described by Newman and Samson, 102 who reported that perfusion problems identified with SPY ® in four of eight patients undergoing free-flap breast reconstruction led to interventions that prevented flap necrosis in three patients. The fourth patient had no intervention and subsequently required reoperative flap salvage due to venous congestion. 102 Similarly, Komorowska-Timek and Gurtner 56 reported a reduction in postoperative complications after breast reconstruction from a historical value of 15.1% in more than 200 patients to 4% in 24 cases using SPY ® . Another study by Newman et al 105 showed SPY ® imaging to have 100% sensitivity and 91% specificity for intraoperative prediction of wound complications in women undergoing skin-sparing mastectomy. Phillips et al 99 found that SPY ® predicted flap necrosis in 19 of 21 patients undergoing breast reconstruction, yielding a sensitivity level of 90%. Phillips et al 99 further observed that assessment using SPY ® technology was nearly three times more accurate than fluorescein dye angiography in predicting skin-flap necrosis in patients undergoing breast reconstruction. More recently, Sood and Glat . SPY ® technology has also been shown to be useful for aiding flap perfusion assessment in patients undergoing head and neck surgery. 104, 106 Chatterjee et al 107 conducted a cost-effectiveness analysis of laser-assisted ICG angiography with SPY ® technology in immediate breast reconstruction patients who underwent mastectomy followed by autologous free-flap surgery at a single institution. In this study, the mean incremental cost-utility ratio (representing the added cost to prolong a patient's life by 1 year of perfect health) was calculated for patient groups who underwent laser-assisted ICG angiography versus those who did not. Cost-utility ratios were calculated on the basis of cost of surgical procedure (per-procedure price for use of laserassisted ICG angiography was set at $1,295 in 2011 dollars), probability of postsurgical complications, and expected quality-adjusted life years. According to the investigators' review of published literature, overall complication rates were 26.5% without laser-assisted ICG angiography versus 5% with ICG angiography. Use of ICG angiography was considered cost-effective if the cost-utility ratio was between $0 and $50,000 per quality-adjusted life year. The analysis revealed an incremental cost-utility ratio of $3,517 (cost per quality-adjusted life year gained); use of laser-assisted ICG angiography was cost-effective when the complication rate without ICG angiography was 4% or more.
Discussion: future applications of emerging tissue perfusion technologies
Reconstructive surgeries, including complex ventral hernia repair, are often marked by postoperative wound-healing complications related to poor tissue perfusion. Older technologies that allow for quantitative assessment of tissue perfusion pose significant limitations and are not widely used. Currently, most surgeons rely upon clinical judgment, gauging tissue viability on the basis of subjective assessments of tissue turgor, perfusion, temperature, and bleeding.
In order to improve postoperative recovery for patients undergoing reconstructive surgery, novel methods for intraoperative assessment of tissue perfusion (eg, spectroscopic and ICG imaging) have been successfully developed in recent years. Spectroscopic imaging technologies, such as NIRS and OPS, appear promising but continue to pose important challenges, including a limited depth of tissue visualization that may limit usefulness in certain clinical situations. Nevertheless, the hand-held portability and high-quality imaging of OPS technology and its ease of use may further its application, particularly in situations where injection of contrast dye is contraindicated. ICG-based laser-fluorescence imaging systems have enjoyed relatively greater clinical investigation than OPS for reconstructive procedures. lower extremity reconstruction, 71 organ transplant, 82 and coronary artery bypass graft procedures. 82 It is likely that the greatest benefits associated with these novel technologies will be rooted in their potential to finally provide clinicians with highly accurate, real-time information regarding the precise location of poorly perfused tissue during surgery. From this perspective, intraoperative quantitative perfusion assessment presents the surgeon with an opportunity to optimize perfusion at the time of herniorrhaphy, rather than waiting for clinical signs of poor perfusion or related complications to emerge postoperatively. It is now possible for surgeons to intraoperatively and proactively debride tissue as needed, regardless of whether the surgical wound is closed or left open at the end of surgery and without having to wait for signs of necrosis to appear before taking action. Early evidence from published clinical reports supports the use of such technologies and describes cases in which these technologies have been successfully used to intraoperatively optimize tissue perfusion and potentially avoid perfusion-related wound-healing complications such as flap necrosis. 71, 95 Because such complications are associated with postoperative debridement, secondary revisional surgery, lengthened hospital stay, and complex recovery, the potential clinical and economic benefits of these technologies for patients and health systems should not be underestimated.
On the basis of their utility for real-time assessment of tissue-flap viability in other types of reconstructive procedures, it is reasonable to propose that these novel technologies will also have good use in abdominal wall reconstruction procedures such as ventral hernia repair, where accurate assessment of tissue viability is just as critical as in other settings. Although both OPS and ICG-based tissue perfusion technologies appear promising, further study is needed in high-quality clinical trials. Their usefulness as a means to help surgeons prevent avoidable postsurgical complications will be solidified with further study and clinical exposure across various types of reconstructive surgeries. 
